ITOH Toshiaki | Drug Safety Research Center, Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd.

スポンサーリンク

概要

関連著者

Kirkland David
Hazleton Microtest
Ito T
Kyowa Hakko Kogyo Co. Ltd. Yamaguchi Jpn
Takahashi Nobuo
Drug Safety Research Center Tokushima Research Institute Otsuka Pharmaceutical Co. Ltd.
SHIBAHARA Toshikazu
Drug Safety Research Center, Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd.
KANEKO Etsuko
Drug Safety Research Center, Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd.
ITOH Toshiaki
Drug Safety Research Center, Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd.
AWOGI Takumi
Drug Safety Research Center, Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd.
TSUSHIMOTO Gen
Drug Safety Research Center, Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd.
MARSHALL Richard
Hazleton Microtest
Awogi Takumi
Department Of Toxicology Tokushima Research Institute Otsuka Pharmaceutical Co. Ltd.
Kaneko Etsuko
Drug Safety Research Center Tokushima Research Institute Otsuka Pharmaceutical Co. Ltd.
Tsushimoto Gen
Drug Safety Research Center Tokushima Research Institute Otsuka Pharmaceutical Co. Ltd.
Itoh Tadanobu
Department Of Pharmacology School Of Dentistry Iwate Medical University
Shibahara Toshikazu
Drug Safety Research Center Tokushima Research Institute Otsuka Pharmaceutical Co. Ltd.

もっと見る

著作論文

MUTAGENIC AND CLASTOGENIC PROPERTIES OF (3-[3-(6-BENZOYLOXY-3-CYANO-2-PYRIDYLOXYCARBONYL)BENZOYL]-1-ETHOXYMETHYL-5-FLUOROURACIL)(BOF-A2), A NEW 5-FLUOROURACIL DERIVATIVE WITH ANTI-TUMOUR ACTIVITY

スポンサーリンク